# Raffit Hassan

Source: https://onco.cc/people/raffit-hassan/  
OnCo record `raffit-hassan` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Made mesothelin a drug target, from immunotoxins to ADCs and CAR-T, and leads NCI's mesothelioma programme.

## Summary

Raffit Hassan is Chief of the Thoracic and GI Malignancies Branch at the National Cancer Institute. He is a thoracic oncologist known for making mesothelin a drug target, with work on mesothelin biology and mesothelin-directed agents including the immunotoxins SS1P and LMB-100 and the antibody-drug conjugate anetumab. His selected paper asks whether mesothelin immunotherapy for cancer is ready for prime time. He leads NCI's mesothelioma programme, and his work underpins current CAR-T and ADC efforts in mesothelioma and pancreatic cancer.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Chief, Thoracic and GI Malignancies Branch
- Specialisms: Mesothelioma; Mesothelin-targeted therapy; Immunotoxins

## Sources

- NCI CCR profile: https://ccr.cancer.gov/staff-directory/raffit-hassan
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Hassan%20R%5BAuthor%5D

## Connected records

- cancers: [Mesothelioma](https://onco.cc/cancers/mesothelioma/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- targets: [Mesothelin](https://onco.cc/targets/mesothelin/)
- institutions: [National Cancer Institute (NIH)](https://onco.cc/institutions/nci/), [NCI Center for Cancer Research (intramural programme)](https://onco.cc/institutions/nci-ccr/)

---
JSON: https://onco.cc/api/v1/entities/raffit-hassan.json